Lorillard (LO)
Lorillard R&D Expense
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these LO related companies
LO News
@McTiernanJames Most likely why its been selling off, however, soon I think $LO will get taken out by someone at about 150 a share
about 15 hours ago by Bjedz
about 15 hours ago by Bjedz
EBR: Watchlist/worksheet/4 Trading Ideas: $ALXN $ARNA $RGLD $LO http://stks.co/40hX
about 21 hours ago by TheEquitiesRoom
about 21 hours ago by TheEquitiesRoom
Rode the lower fib fan line and finally collapsed. Gap to fill below at 113.74 $LO http://chart.ly/2qgawov
about 2 days ago by 1nvestor
about 2 days ago by 1nvestor
Lorillard: 4.8% Dividend Yield and its Newport Brand is Gaining Market Share http://stks.co/3zWM $LO $MO $RAI
about 5 days ago by ycharts
about 5 days ago by ycharts
Avg put/call ratio of $SPX components is 2.04. Charts of those with P/C >5: $BIG $PBCT $ABC $LO $DV $HUM $FISV http://stks.co/3vLu
about 9 days ago by Attitrade
about 9 days ago by Attitrade
$LO Insider Sale: $3.6M of stock sold by Hennighausen Charles E. on May 7, 2012 http://stks.co/3kQi
about 21 days ago by MarketBrief
about 21 days ago by MarketBrief
$LO MACD Bearish Chart pat Possible Trend Reversal
RSI Neutral Up/Down vol pat under Distrib 50/200d MA Bullish Suppt 131.47 Resist133.98
about 23 days ago by MACDaddy
about 23 days ago by MACDaddy
Lorillard to Participate in the Goldman Sachs Consumer Products Symposium On Thursday, May 10, 2012
May 03, 12:15PM PR Newswire
May 03, 12:15PM PR Newswire
$LO ~ looks like the 133.35 level was support. 136.50 top of range.
about 28 days ago by Liquid_Trader
about 28 days ago by Liquid_Trader
Orderly selling in $LO today, low volume on the uptick. Investors rotating $$ into high beta plays?
about 29 days ago by samlee22
about 29 days ago by samlee22
Why tobacco stocks are far from being on their death bed $PM $MO $RAI $LO http://stks.co/3bXC
about 29 days ago by eyeonequities
about 29 days ago by eyeonequities
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| LO | 124.77 | -0.07 | -0.06% | 16.48B |
| LNT | 44.10 | +0.06 | +0.14% | 4.889B |
| KLIC | 10.89 | +0.07 | +0.65% | 797.65M |
| KLD | 57.54 | +0.47 | +0.83% | |
| KLAC | 46.84 | +0.69 | +1.50% | 7.695B |
| KKR | 12.17 | +0.47 | +4.02% | 2.711B |
| KKD | 6.58 | +0.10 | +1.54% | 441.29M |
| KITD | 3.76 | +0.21 | +5.92% | 164.51M |
| KIRK | 10.78 | +0.45 | +4.36% | 189.14M |
| KIPS | 1.20 | -0.05 | -4.00% | 20.31M |
